Skip to content
Sunday 9 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE
MorningWire

European business, markets and politics

FTSE 100
10,901.09
+0.31%
DAX
26,319.45
+0.69%
CAC 40
8,714.93
+0.17%
STOXX 50
6,523.86
+0.33%
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
More
GermanyFranceBankingAIEnergyFintechPropertyCapital Markets
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
  • DE
Tuesday 05 May 2026 12:06 pm

Clinisys France Achieves Qualiopi Certification for Training Excellence

By: Business Wire

Add as a preferred source on Google

Clinisys, a global provider of intelligent laboratory informatics solutions, today announced that Clinisys France has officially obtained the Qualiopi certification for its training activities. This nationally recognized certification confirms that Clinisys’s training organization complies with the Référentiel National Qualité (RNQ), the French State quality framework for training providers, and is therefore eligible to deliver training that may be financed through public and mutualized funding mechanisms.

Qualiopi is a mandatory quality certification in France for organizations delivering professionally funded training. By achieving this certification, Clinisys France further reinforces its commitment to structured, measurable, and high-quality training programs that enable laboratories and healthcare organizations to maximize their Clinisys solutions.

For customers in France, Qualiopi certification strengthens confidence in the quality, consistency, and effectiveness of training delivered across the Clinisys portfolio, including Clinisys™ GLIMS, Clinisys™ GLIMS Genetics, Clinisys™ GLIMS HLA Transplant, Clinisys™ CyberLab, and Clinisys™ DaVinci. The certification applies to Clinisys’s training processes and delivery organization, ensuring that training services for these solutions meet nationally defined quality standards.

The certification is valid through November 2028 and includes a required surveillance audit scheduled for 2027 as part of the three-year certification cycle. Qualiopi certification reflects Clinisys France’s long-term commitment to maintaining auditable, continuously improved training processes in alignment with national requirements.

“Qualiopi certification is a strong recognition of the rigor, structure, and professionalism of our training organization in France,” said Michael Simpson, CEO of Clinisys. “Beyond regulatory compliance, it confirms our commitment to helping laboratories and healthcare organizations fully realize the value of their Clinisys solutions through high-quality, accessible, and measurable training.”

Supporting customer performance through certified training

The Qualiopi framework defines demanding standards across the entire training lifecycle, including needs analysis, program design, delivery, evaluation, documentation, accessibility considerations, and continuous improvement. As a result, Clinisys customers benefit from:

  • Well-trained, autonomous users
  • Effective use of Clinisys solutions, including advanced and complementary modules
  • Simplified internal processes and reduced re-training efforts
  • High and sustainable user satisfaction
  • Access to eligible training funding, enabling scalable skills development plans

Through Qualiopi-certified training services, Clinisys strengthens its position as a trusted and compliant training partner for laboratories and healthcare institutions operating in France’s highly regulated environment.

A collective achievement and an ongoing commitment

Achieving Qualiopi certification required significant cross-functional collaboration across Clinisys, including the standardization of training programs, alignment with national quality requirements, formalization of evaluation and feedback mechanisms, internal audits, and the qualification and ongoing assessment of certified trainers.

Qualiopi is not a one-time achievement. Maintaining certification requires continued discipline, consistent delivery practices, comprehensive documentation, and ongoing monitoring of training quality and learner feedback. Clinisys remains fully committed to sustaining these standards and further enhancing its training offering for our customers in France.

“This certification establishes a strong foundation for the future of Clinisys training in France,” added Nicolas Blanc, Vice-President Sales EU Healthcare. “It supports customer growth, reinforces trust, and ensures that our training remains a strategic driver of software adoption and operational excellence.”

About Clinisys

Clinisys enables healthier and safer communities as a global provider of intelligent laboratory informatics solutions and expertise that redefine the modern laboratory across healthcare, life sciences, and public health and safety. Millions of laboratory results and data insights are generated every day using Clinisys’s platform and cloud-based solutions in over 7,000 laboratories across 42 countries.

To learn more, visit: www.clinisys.com

Clinisys France team celebrating Qualiopi certification for excellence in training, highlighting compliance with RNQ stand...

View source version on businesswire.com: https://www.businesswire.com/news/home/20260505377910/en/

Contact

Media Contact

Michele Schicchi
SVP, Global Marketing and Corporate Communications, CMO
Clinisys
[email protected]

Company Logo
Company Logo
Read more

Miami heat: Why climate could be key in 40C England v Norway World Cup quarter-final

Business professionals discussing strategies in a modern office setting with charts and graphs on a large screen in the ba...

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • Businesswire

Categories

  • Award
  • Product/Service

Trending Articles

  • Thames Water faces fresh threat to survival after pensions regulation breach

  • PwC’s Embankment HQ to get major makeover ahead of Canary Wharf move

  • Family feud: London estate agent Winkworth sues chair over plot with wife to oust son from board

  • As it happened: Stocks rise despite new tensions in Strait of Hormuz; Oil price climbs

  • A tribute to wine legend Matthew Jukes by his friend Libby Brodie

More from Morning Wire

  • Miami heat: Why climate could be key in 40C England v Norway World Cup quarter-final

    Sport Business
    Business professionals discussing strategies in a modern office setting with charts and graphs on a large screen in the ba...
  • AI firms targeting London’s rare book shops in ‘dystopian’ hunt for training data

    AI
    Bloomsbury has reported results ahead of consensus expectations
  • Curaleaf Launches Free CPD-Accredited Platform to Close Medical Cannabis Training Gap for UK Healthcare Professionals

    Business Wire
  • Burnham has a chance to build trust in AI

    Opinion
    Andy Burnham discussing AI advancements at a business conference podium with delegates in the background
  • From crown jewel to €180m courtroom battle: The investor revolt targeting Atos

    Markets
    Atos logo prominently displayed on a modern office building, highlighting its corporate presence and technological expertise.
  • e.l.f. Cosmetics is Giving Away Thousands of Driving Lessons to UK Learners

    Business Wire
  • Anthropic payout piles pressure on UK ministers in AI copyright row

    Tech
    Smartphone displaying the Claude by Anthropic AI assistant app, showing the app icon and interface.
  • Devolution is the shakeup Britain needs

    Opinion
    Andy Burnham speaking passionately at a public event, wearing a suit, highlighting his role as a prominent political figure.
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Business

  • Markets
  • Banking
  • Technology
  • Energy
  • Property
  • Fintech

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook